Market revenue in 2023 | USD 302.4 million |
Market revenue in 2030 | USD 437.9 million |
Growth rate | 5.4% (CAGR from 2023 to 2030) |
Largest segment | Tablets |
Fastest growing segment | Capsules |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Tablets, Capsules, Powders, Granules |
Key market players worldwide | Catalent Inc, Lonza Group Ltd, Boehringer Ingelheim, Jubilant Pharmova, Novacyt SA, Thermo Fisher Scientific Inc, Recipharm, CordenPharma, Siegfried Holding AG, Piramal Pharma Solutions, AbbVie Inc |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to oral solid dosage contract manufacturing market will help companies and investors design strategic landscapes.
Tablets was the largest segment with a revenue share of 33.5% in 2023. Horizon Databook has segmented the Mexico oral solid dosage contract manufacturing market based on tablets, capsules, powders, granules covering the revenue growth of each sub-segment from 2018 to 2030.
According to the International Trade Administration, updated in November 2023, Mexico is the 15thlargest market for pharmaceuticals globally and the second-largest in Latin America after Brazil. In addition, the country’s pharmaceutical market is divided into patented medicines, presenting 51% of the market, generics, presenting 35%, and over-the-counter products, with the remaining 14% by value.
Mexico is attracting international pharma companies and contract manufacturers. In addition, the country provides a favorable market environment to attract R&D investment and expansion, thereby stimulating the demand for CMO.
Horizon Databook provides a detailed overview of country-level data and insights on the Mexico oral solid dosage contract manufacturing market , including forecasts for subscribers. This country databook contains high-level insights into Mexico oral solid dosage contract manufacturing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account